{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:29:40Z","timestamp":1770229780756,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["215799\/Z\/19\/Z"],"award-info":[{"award-number":["215799\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The role of inflammation in cardiovascular pathophysiology has gained a lot of research interest in recent years. Cardiovascular Magnetic Resonance has been a powerful tool in the non-invasive assessment of inflammation in several conditions. More recently, Ultrasmall superparamagnetic particles of iron oxide have been successfully used to evaluate macrophage activity and subsequently inflammation on a cellular level. Current evidence from research studies provides encouraging data and confirms that this evolving method can potentially have a huge impact on clinical practice as it can be used in the diagnosis and management of very common conditions such as coronary artery disease, ischaemic and non-ischaemic cardiomyopathy, myocarditis and atherosclerosis. Another important emerging concept is that of myocardial energetics. With the use of phosphorus magnetic resonance spectroscopy, myocardial energetic compromise has been proved to be an important feature in the pathophysiological process of several conditions including diabetic cardiomyopathy, inherited cardiomyopathies, valvular heart disease and cardiac transplant rejection. This unique tool is therefore being utilized to assess metabolic alterations in a wide range of cardiovascular diseases. This review systematically examines these state-of-the-art methods in detail and provides an insight into the mechanisms of action and the clinical implications of their use.<\/jats:p>","DOI":"10.1186\/s12880-021-00695-0","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T12:02:59Z","timestamp":1636372979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Myocardial inflammation and energetics by cardiac MRI: a review of emerging techniques"],"prefix":"10.1186","volume":"21","author":[{"given":"Vasiliki","family":"Tsampasian","sequence":"first","affiliation":[]},{"given":"Andrew J.","family":"Swift","sequence":"additional","affiliation":[]},{"given":"Hosamadin","family":"Assadi","sequence":"additional","affiliation":[]},{"given":"Amrit","family":"Chowdhary","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Swoboda","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Sammut","sequence":"additional","affiliation":[]},{"given":"Amardeep","family":"Dastidar","sequence":"additional","affiliation":[]},{"given":"Jordi Broncano","family":"Cabrero","sequence":"additional","affiliation":[]},{"given":"Javier Royuela","family":"Del Val","sequence":"additional","affiliation":[]},{"given":"Sunil","family":"Nair","sequence":"additional","affiliation":[]},{"given":"Robin","family":"Nijveldt","sequence":"additional","affiliation":[]},{"given":"Alisdair","family":"Ryding","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Sawh","sequence":"additional","affiliation":[]},{"given":"Chiara","family":"Bucciarelli-Ducci","sequence":"additional","affiliation":[]},{"given":"Eylem","family":"Levelt","sequence":"additional","affiliation":[]},{"given":"Vassilios","family":"Vassiliou","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-169X","authenticated-orcid":false,"given":"Pankaj","family":"Garg","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"695_CR1","doi-asserted-by":"crossref","unstructured":"Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target, vol 16, Current Atherosclerosis Reports. Current Medicine Group LLC 1; 2014.","DOI":"10.1007\/s11883-014-0435-z"},{"issue":"12","key":"695_CR2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"1","key":"695_CR3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12968-015-0183-4","volume":"17","author":"SR Alam","year":"2015","unstructured":"Alam SR, Stirrat C, Richards J, Mirsadraee S, Semple SIK, Tse G, et al. Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide. J Cardiovasc Magn Reson. 2015;17(1):83.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"695_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11239-019-02026-1","volume":"49","author":"RC Becker","year":"2020","unstructured":"Becker RC, Owens AP, Sadayappan S. Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy. J Thromb Thrombolysis. 2020;49(2):177\u201383.","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"695_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pin.12868","volume":"70","author":"K Imanaka-Yoshida","year":"2020","unstructured":"Imanaka-Yoshida K. Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy. Pathol Int. 2020;70(1):1\u201311.","journal-title":"Pathol Int"},{"key":"695_CR6","volume-title":"Cardiovascular magnetic resonance: Applications and practical considerations for the general cardiologist. Heart","author":"JR Arnold","year":"2019","unstructured":"Arnold JR, McCann GP. Cardiovascular magnetic resonance: Applications and practical considerations for the general cardiologist. Heart, vol. 106. London: BMJ Publishing Group; 2019."},{"key":"695_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yjmcc.2019.03.013","volume":"130","author":"G Manno","year":"2019","unstructured":"Manno G, Bentivegna R, Morreale P, Nobile D, Santangelo A, Novo S, et al. Chronic inflammation: a key role in degeneration of bicuspid aortic valve. J Mol Cell Cardiol. 2019;130:59\u201364.","journal-title":"J Mol Cell Cardiol"},{"key":"695_CR8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1568010054022024","volume":"4","author":"N Fujiwara","year":"2005","unstructured":"Fujiwara N, Kobayashi K. Macrophages in inflammation. Current drug targets: inflammation and allergy. Curr Drug Targets Inflamm Allergy. 2005;4:281\u20136.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"3","key":"695_CR9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2019190477","volume":"293","author":"KL Nguyen","year":"2019","unstructured":"Nguyen KL, Yoshida T, Kathuria-Prakash N, Zaki IH, Varallyay CG, Semple SI, et al. Multicenter safety and practice for off-label diagnostic use of ferumoxytol in MRI. Radiology. 2019;293(3):554\u201364.","journal-title":"Radiology"},{"key":"695_CR10","unstructured":"Merinopoulos I, Gunawardena T, Stirrat C, Cameron D, Eccleshall SC, Dweck MR, et al. Diagnostic applications of ultrasmall superparamagnetic particles of iron oxide for imaging myocardial and vascular inflammation. JACC: Cardiovascular Imaging. 2020. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1936878X20306331"},{"issue":"2","key":"695_CR11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jcmg.2020.02.001","volume":"14","author":"J Lagan","year":"2021","unstructured":"Lagan J, Naish JH, Simpson K, Zi M, Cartwright EJ, Foden P, et al. Substrate for the myocardial inflammation-heart failure hypothesis identified using novel USPIO methodology. JACC Cardiovasc Imaging. 2021;14(2):365\u201376.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"695_CR12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/CIRCIMAGING.112.974907","volume":"5","author":"SR Alam","year":"2012","unstructured":"Alam SR, Shah ASV, Richards J, Lang NN, Barnes G, Joshi N, et al. Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience. Circ Cardiovasc Imaging. 2012;5(5):559\u201365.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"695_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2011.06.004","volume":"163","author":"A Yilmaz","year":"2013","unstructured":"Yilmaz A, R\u00f6sch S, Klingel K, Kandolf R, Helluy X, Hiller K-H, et al. Magnetic resonance imaging (MRI) of inflamed myocardium using iron oxide nanoparticles in patients with acute myocardial infarction\u2014preliminary results. Int J Cardiol. 2013;163(2):175\u201382.","journal-title":"Int J Cardiol"},{"issue":"6","key":"695_CR14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/eurheartj\/ehs366","volume":"34","author":"A Yilmaz","year":"2013","unstructured":"Yilmaz A, Dengler MA, van der Kuip H, Yildiz H, R\u00f6sch S, Klumpp S, et al. Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach. Eur Heart J. 2013;34(6):462\u201375.","journal-title":"Eur Heart J"},{"issue":"19","key":"695_CR15","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/heartjnl-2016-311018","volume":"103","author":"CG Stirrat","year":"2017","unstructured":"Stirrat CG, Alam SR, MacGillivray TJ, Gray CD, Dweck MR, Raftis J, et al. Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction. Heart. 2017;103(19):1528\u201335.","journal-title":"Heart"},{"issue":"1","key":"695_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13019-017-0568-6","volume":"12","author":"SR Alam","year":"2017","unstructured":"Alam SR, Stirrat C, Spath N, Zamvar V, Pessotto R, Dweck MR, et al. Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery. J Cardiothorac Surg. 2017;12(1):1\u201310.","journal-title":"J Cardiothorac Surg"},{"issue":"2","key":"695_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijcard.2007.08.102","volume":"132","author":"H Abdel-Aty","year":"2009","unstructured":"Abdel-Aty H, Cocker M, Friedrich MG. Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: Insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol. 2009;132(2):291\u20133.","journal-title":"Int J Cardiol"},{"issue":"10","key":"695_CR18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCULATIONAHA.117.031841","volume":"137","author":"C Scally","year":"2018","unstructured":"Scally C, Rudd A, Mezincescu A, Wilson H, Srivanasan J, Horgan G, et al. Persistent long-term structural, functional, and metabolic changes after stress-induced (takotsubo) cardiomyopathy. Circulation. 2018;137(10):1039\u201348.","journal-title":"Circulation"},{"issue":"24","key":"695_CR19","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"695_CR20","first-page":"300","volume":"104","author":"CG Stirrat","year":"2018","unstructured":"Stirrat CG, Alam SR, MacGillivray TJ, Gray CD, Dweck MR, Dibb K, et al. Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis. Heart (British Cardiac Society). 2018;104(4):300\u20135.","journal-title":"Heart (British Cardiac Society)"},{"key":"695_CR21","doi-asserted-by":"crossref","unstructured":"Lagan J, Naish JH, Simpson K, Zi M, Cartwright EJ, Foden P, et al. Substrate for the myocardial inflammation\u2013heart failure hypothesis identified using novel USPIO methodology. JACC: Cardiovascular Imaging. 2020.","DOI":"10.1016\/j.jcmg.2020.02.001"},{"issue":"10","key":"695_CR22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.CIR.0000118493.13323.81","volume":"109","author":"H Mahrholdt","year":"2004","unstructured":"Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis. Circulation. 2004;109(10):1250\u20138.","journal-title":"Circulation"},{"key":"695_CR23","first-page":"159","volume-title":"Chronic heart failure and inflammation. Circulation research","author":"SA Dick","year":"2016","unstructured":"Dick SA, Epelman S. Chronic heart failure and inflammation. Circulation research, vol. 119. Philadelphia: Lippincott Williams and Wilkins; 2016. p. 159\u201376."},{"issue":"22","key":"695_CR24","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.jacc.2009.03.018","volume":"53","author":"TY Tang","year":"2009","unstructured":"Tang TY, Howarth SPS, Miller SR, Graves MJ, Patterson AJ, U-King-Im J-M, et al. The ATHEROMA (atorvastatin therapy: effects on reduction of macrophage activity) study: evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol. 2009;53(22):2039\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"695_CR25","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1161\/01.STR.0000236063.47539.99","volume":"37","author":"T Tang","year":"2006","unstructured":"Tang T, Howarth SPS, Miller SR, Trivedi R, Graves MJ, King-Im JU, et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke. 2006;37(9):2266\u201370.","journal-title":"Stroke"},{"issue":"1","key":"695_CR26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejvs.2008.02.006","volume":"36","author":"TY Tang","year":"2008","unstructured":"Tang TY, Moustafa RR, Howarth SP, Walsh SR, Boyle JR, Li ZY, et al. Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis. Eur J Vasc Endovasc Surg. 2008;36(1):53\u20135.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"263","key":"695_CR27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2017.06.020","volume":"1","author":"LP Smits","year":"2017","unstructured":"Smits LP, Tiessens F, Zheng KH, Stroes ES, Nederveen AJ, Coolen BF. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation. Atherosclerosis. 2017;1(263):211\u20138.","journal-title":"Atherosclerosis"},{"issue":"9","key":"695_CR28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.117.028433","volume":"136","author":"MA3RS Study Investigators","year":"2017","unstructured":"MA3RS Study Investigators. Aortic wall inflammation predicts abdominal aortic aneurysm expansion, rupture, and need for surgical repair. Circulation. 2017;136(9):787\u201397.","journal-title":"Circulation"},{"issue":"5","key":"695_CR29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2008.496","volume":"75","author":"EA Neuwelt","year":"2009","unstructured":"Neuwelt EA, Hamilton BE, Varallyay CG, Rooney WR, Edelman RD, Jacobs PM, et al. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int. 2009;75(5):465\u201374.","journal-title":"Kidney Int"},{"key":"695_CR30","unstructured":"Research C for DE and. FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol). FDA. 2019 [cited 2021 Aug 7]; https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-strengthens-warnings-and-changes-prescribing-instructions-decrease."},{"issue":"5","key":"695_CR31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ajh.25060","volume":"93","author":"NF Adkinson","year":"2018","unstructured":"Adkinson NF, Strauss WE, Macdougall IC, Bernard KE, Auerbach M, Kaper RF, et al. Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: a randomized trial. Am J Hematol. 2018;93(5):683\u201390.","journal-title":"Am J Hematol"},{"issue":"11","key":"695_CR32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S. The failing heart\u2014an engine out of fuel. N Engl J Med. 2007;356(11):1140\u201351.","journal-title":"N Engl J Med"},{"issue":"3","key":"695_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/mrm.1910140302","volume":"14","author":"PA Bottomley","year":"1990","unstructured":"Bottomley PA, Hardy CJ, Roemer PB. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med. 1990;14(3):425\u201334.","journal-title":"Magn Reson Med"},{"issue":"24","key":"695_CR34","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1161\/01.CIR.0000072789.89096.10","volume":"107","author":"M Scheuermann-Freestone","year":"2003","unstructured":"Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation. 2003;107(24):3040\u20136.","journal-title":"Circulation"},{"issue":"10","key":"695_CR35","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/CIRCULATIONAHA.109.873273","volume":"121","author":"GN Shivu","year":"2010","unstructured":"Shivu GN, Phan TT, Abozguia K, Ahmed I, Wagenmakers A, Henning A, et al. Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus. Circulation. 2010;121(10):1209\u201315.","journal-title":"Circulation"},{"issue":"46","key":"695_CR36","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/eurheartj\/ehv442","volume":"37","author":"E Levelt","year":"2016","unstructured":"Levelt E, Rodgers CT, Clarke WT, Mahmod M, Ariga R, Francis JM, et al. Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur Heart J. 2016;37(46):3461\u20139.","journal-title":"Eur Heart J"},{"issue":"24","key":"695_CR37","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/eurheartj\/ehv120","volume":"36","author":"S Dass","year":"2015","unstructured":"Dass S, Cochlin LE, Suttie JJ, Holloway CJ, Rider OJ, Carden L, et al. Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction. Eur Heart J. 2015;36(24):1547\u201354.","journal-title":"Eur Heart J"},{"issue":"1","key":"695_CR38","doi-asserted-by":"publisher","first-page":"O68","DOI":"10.1186\/1532-429X-15-S1-O68","volume":"15","author":"S Dass","year":"2013","unstructured":"Dass S, Holloway C, Suttie J, Mahmod M, Sever E, Watkins H, et al. (2013) Patients with Dilated Cardiomyopathy (DCM) have appropriate myocardial oxygenation response to vasodilator stress. J Cardiovasc Magn Reson. 2013;15(1):O68. https:\/\/doi.org\/10.1186\/1532-429X-15-S1-O68.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"16","key":"695_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1532-429X-16-29","volume":"29","author":"M Mahmod","year":"2014","unstructured":"Mahmod M, Francis JM, Pal N, Lewis A, Dass S, De Silva R, et al. Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction. J Cardiovasc Magn Reson. 2014;29(16):29.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"695_CR40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1148\/radiology.181.1.1887057","volume":"181","author":"PA Bottomley","year":"1991","unstructured":"Bottomley PA, Weiss RG, Hardy CJ, Baumgartner WA. Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. Radiology. 1991;181(1):67\u201375.","journal-title":"Radiology"},{"issue":"3","key":"695_CR41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.21037\/cdt-20-275","volume":"10","author":"MA Peterzan","year":"2020","unstructured":"Peterzan MA, Lewis AJM, Neubauer S, Rider OJ. Non-invasive investigation of myocardial energetics in cardiac disease using 31P magnetic resonance spectroscopy. Cardiovasc Diagn Ther. 2020;10(3):625\u201335.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"6","key":"695_CR42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.21037\/qims.2017.11.03","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu Y, Gu Y, Yu X. Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review. Quant Imaging Med Surg. 2017;7(6):707\u201326.","journal-title":"Quant Imaging Med Surg"},{"issue":"14","key":"695_CR43","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.0000012466.50373.E8","volume":"105","author":"H Taegtmeyer","year":"2002","unstructured":"Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation. 2002;105(14):1727\u201333.","journal-title":"Circulation"},{"issue":"3","key":"695_CR44","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.1997.77.3.731","volume":"77","author":"DF Rolfe","year":"1997","unstructured":"Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev. 1997;77(3):731\u201358.","journal-title":"Physiol Rev"},{"issue":"4","key":"695_CR45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCRESAHA.114.301863","volume":"114","author":"AN Carley","year":"2014","unstructured":"Carley AN, Taegtmeyer H, Lewandowski ED. Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart. Circ Res. 2014;114(4):717\u201329.","journal-title":"Circ Res"},{"issue":"6","key":"695_CR46","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1016\/S0021-9258(19)83652-9","volume":"260","author":"JA Bittl","year":"1985","unstructured":"Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J Biol Chem. 1985;260(6):3512\u20137.","journal-title":"J Biol Chem"},{"key":"695_CR47","doi-asserted-by":"crossref","unstructured":"Levelt E, Rodgers CT, Clarke WT, Mahmod M, Ariga R, Francis JM, et al. Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur Heart J. 2016.","DOI":"10.1093\/eurheartj\/ehv442"},{"issue":"1","key":"695_CR48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12968-017-0397-8","volume":"19","author":"E Levelt","year":"2017","unstructured":"Levelt E, Piechnik SK, Liu A, Wijesurendra RS, Mahmod M, Ariga R, et al. Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease. J Cardiovasc Magn Reson. 2017;19(1):81.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"6","key":"695_CR49","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/CIRCHEARTFAILURE.114.002169","volume":"8","author":"S Dass","year":"2015","unstructured":"Dass S, Holloway CJ, Cochlin LE, Rider OJ, Mahmod M, Robson M, et al. No evidence of myocardial oxygen deprivation in nonischemic heart failure. Circ Heart Fail. 2015;8(6):1088\u201393.","journal-title":"Circ Heart Fail"},{"issue":"5","key":"695_CR50","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/mrm.10130","volume":"47","author":"PA Bottomley","year":"2002","unstructured":"Bottomley PA, Ouwerkerk R, Lee RF, Weiss RG. Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med. 2002;47(5):850\u201363.","journal-title":"Magn Reson Med"},{"issue":"215","key":"695_CR51","doi-asserted-by":"crossref","first-page":"215re3","DOI":"10.1126\/scitranslmed.3007328","volume":"5","author":"PA Bottomley","year":"2013","unstructured":"Bottomley PA, Panjrath GS, Lai S, Hirsch GA, Wu K, Najjar SS, et al. Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. Sci Transl Med. 2013;5(215):215re3.","journal-title":"Sci Transl Med"},{"issue":"14","key":"695_CR52","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.119.042770","volume":"141","author":"JJ Rayner","year":"2020","unstructured":"Rayner JJ, Peterzan MA, Watson WD, Clarke WT, Neubauer S, Rodgers CT, et al. Myocardial energetics in obesity. Circulation. 2020;141(14):1152\u201363.","journal-title":"Circulation"},{"issue":"24","key":"695_CR53","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCULATIONAHA.119.043450","volume":"141","author":"MA Peterzan","year":"2020","unstructured":"Peterzan MA, Clarke WT, Lygate CA, Lake HA, Lau Justin YC, Miller JJ, et al. Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction. Circulation. 2020;141(24):1971\u201385.","journal-title":"Circulation"},{"issue":"6","key":"695_CR54","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/CIRCRESAHA.119.316260","volume":"126","author":"OJ Rider","year":"2020","unstructured":"Rider OJ, Apps A, Miller JJJJ, Lau JYC, Lewis AJM, Peterzan MA, et al. Noninvasive in vivo assessment of cardiac metabolism in the healthy and diabetic human heart using hyperpolarized 13C MRI. Circ Res. 2020;126(6):725\u201336.","journal-title":"Circ Res"},{"issue":"2","key":"695_CR55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jcmg.2020.12.022","volume":"14","author":"ZA Fayad","year":"2021","unstructured":"Fayad ZA, Calcagno C. USPIO-enhanced CMR of myocardial inflammation. JACC Cardiovasc Imaging. 2021;14(2):377\u20138.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-021-00695-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T12:08:10Z","timestamp":1636373290000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-021-00695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1186\/s12880-021-00695-0","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"23 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PG is advisor for Pie Medical Imaging and Medis Medical Imaging. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}